Nuo Therapeutics, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Nuo Therapeutics, Inc. (AURX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$1.93 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-16.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-04-16
- Nuo Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$1.23M.
- Nuo Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-03-31 was -$236.83K.
- Nuo Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2015-12-31 was -$3.13M.
- Nuo Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2015-09-30 was -$2.83M.
- Nuo Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$1.93M.
- Nuo Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$15.02M, a 218.68% decline from fiscal 2014.
- Nuo Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $12.66M, a 1786.95% increase from fiscal 2013.
- Nuo Therapeutics, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2013 was $670.91K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 2 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 5 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 8 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-16 | -$1.93M 10-K · filed 2018-04-16 | |||||
| 2017-09-30 | -$696.85K 10-Q · filed 2017-11-13 | ||||||
| 2016-12-31 | -$7.74M 10-K · filed 2018-04-16 | ||||||
| 2016-09-30 | -$6.48M 10-Q · filed 2017-11-13 | ||||||
| 2016-06-30 | -$4.29M 10-Q · filed 2016-10-24 | ||||||
| 2016-03-31 | -$236.83K 10-Q · filed 2016-10-24 | -$3.37M derived: sum of 2 quarters · filed 2016-10-24 | -$6.20M derived: sum of 3 quarters · filed 2016-10-24 | -$11.13M derived: sum of 4 quarters · filed 2016-10-24 | |||
| 2015-12-31 | -$3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-24 | -$5.96M derived: sum of 2 quarters · filed 2016-10-24 | -$10.90M derived: sum of 3 quarters · filed 2016-10-24 | -$15.02M 10-K · filed 2016-10-24 | |||
| 2015-09-30 | -$2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$7.77M derived: sum of 2 quarters · filed 2015-11-13 | -$11.89M 10-Q · filed 2015-11-13 | -$15.98M derived: sum of 4 quarters · filed 2016-10-24 | |||
| 2015-06-30 | -$4.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$9.06M 10-Q · filed 2015-08-13 | -$13.15M derived: sum of 3 quarters · filed 2016-10-24 | -$18.09M derived: sum of 4 quarters · filed 2016-10-24 | |||
| 2015-03-31 | -$4.13M 10-Q · filed 2016-10-24 | -$8.22M derived: sum of 2 quarters · filed 2016-10-24 | -$13.15M derived: sum of 3 quarters · filed 2016-10-24 | $4.17M derived: sum of 4 quarters · filed 2016-10-24 | |||
| 2014-12-31 | -$4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-24 | -$9.03M derived: sum of 2 quarters · filed 2016-10-24 | $8.29M derived: sum of 3 quarters · filed 2016-10-24 | $12.66M 10-K · filed 2016-10-24 | |||
| 2014-09-30 | -$4.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $12.38M derived: sum of 2 quarters · filed 2015-11-13 | $16.75M 10-Q · filed 2015-11-13 | $15.39M derived: sum of 4 quarters · filed 2015-11-13 | |||
| 2014-06-30 | $17.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $21.69M 10-Q · filed 2015-08-13 | $20.33M derived: sum of 3 quarters · filed 2015-08-13 | ||||
| 2014-03-31 | $4.37M 10-Q · filed 2015-05-14 | $3.01M derived: sum of 2 quarters · filed 2015-05-14 | |||||
| 2013-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $670.91K 10-K · filed 2015-03-31 | |||||
| 2013-09-30 | $2.03M 10-Q · filed 2014-11-13 | ||||||
| 2011-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $1.94M derived: sum of 2 quarters · filed 2012-03-29 | $1.61M 10-K · filed 2012-03-29 | ||||
| 2011-09-30 | $513.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $176.61K 10-Q · filed 2011-11-14 | |||||
| 2011-06-30 | -$337.14K 10-Q · filed 2011-08-15 | ||||||
| 2010-12-31 | $18.12K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | -$430.74K derived: sum of 2 quarters · filed 2012-03-29 | -$1.47M 10-K · filed 2012-03-29 | ||||
| 2010-09-30 | -$448.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$1.49M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | -$1.04M 10-Q · filed 2011-08-15 |